Movano Inc. (MOVE)

NASDAQ: MOVE · Real-Time Price · USD
0.321
-0.009 (-2.73%)
At close: Oct 21, 2024, 4:00 PM
0.323
+0.002 (0.62%)
After-hours: Oct 21, 2024, 5:05 PM EDT
-2.73%
Market Cap 31.76M
Revenue (ttm) 852,000
Net Income (ttm) -26.83M
Shares Out 98.95M
EPS (ttm) -0.41
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 89,703
Open 0.303
Previous Close 0.330
Day's Range 0.303 - 0.338
52-Week Range 0.240 - 1.060
Beta 0.12
Analysts Buy
Price Target 2.00 (+523.05%)
Earnings Date Nov 13, 2024

About MOVE

Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and c... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Mar 23, 2021
Employees 30
Stock Exchange NASDAQ
Ticker Symbol MOVE
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for MOVE stock is "Buy" and the 12-month stock price forecast is $2.0.

Price Target
$2.0
(523.05% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Movano Health Provides Update on FDA Review of EvieMED Ring

The Company continues to work closely with the FDA to bring this pioneering healthcare product to market PLEASANTON, Calif. , Oct. 10, 2024 /PRNewswire/ -- Movano Health  (Nasdaq: MOVE) announced toda...

11 days ago - PRNewsWire

Evie, Movano Health's Smart Ring for Women, is Back In Stock with Key Upgrades

Orders Reopen with Enhancements to AI Powered Health Insights, Sleep and Heart Rate Measurements and More PLEASANTON, Calif. , Sept. 17, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) today announc...

4 weeks ago - PRNewsWire

Movano Health Advances to Final Phase of FDA Review Process for EvieMED Ring

Following the positive outcome of a recent agency meeting, the Company will continue to work closely with the FDA to bring this pioneering healthcare product to market PLEASANTON, Calif. , Sept. 3, 20...

6 weeks ago - PRNewsWire

Movano Inc. (MOVE) Q2 2024 Earnings Call Transcript

Movano Inc. (NASDAQ:MOVE) Q2 2024 Earnings Conference Call August 14, 2024 5:00 PM ET Company Participants Jay Cogan - CFO John Mastrototaro - CEO Tyla Bucher - Chief Marketing Officer Michael Leabma...

2 months ago - Seeking Alpha

Movano Health Reports Q2 2024 Financial Results and Provides Business Update

Prepares for September 17, 2024, Evie Ring back in stock date Announces brand partnership with digital creator Heidi D'Amelio Focuses on launch of EvieMED and securing B2B opportunities Conference Cal...

2 months ago - PRNewsWire

Movano Health Provides Progress Update on EvieMED Regulatory Filing

Company continues to work with FDA to bring this pioneering healthcare product to market PLEASANTON, Calif. , Aug. 5, 2024 /PRNewswire/ --  Movano Health  (Nasdaq:  MOVE) plans to meet with the FDA i...

2 months ago - PRNewsWire

Movano Health to Report Second Quarter 2024 Financial Results on Wednesday August 14, 2024

Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif. , Aug. 5, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report second qua...

2 months ago - PRNewsWire

Movano Health Announces Dr. Fatima Rodriguez Joining July 11 Virtual Event

Allele Capitals' Matt Hughes will moderate future forward panel on enterprise need in wearables for a variety of healthcare applications PLEASANTON, Calif. , June 28, 2024 /PRNewswire/ -- Movano Healt...

4 months ago - PRNewsWire

Movano Health Applies Advanced AI through Deep Learning to Deliver Improved Accuracy of Heart Rate in Motion

Enhancements address significant clinical enterprise need in wearables for a variety of healthcare applications PLEASANTON, Calif., June 13, 2024 /PRNewswire/ -- Movano Health  (Nasdaq:  MOVE) announ...

4 months ago - PRNewsWire

MIT Selects Movano Health for Groundbreaking Study on Long COVID and Chronic Lyme Disease

Pioneering partnership advances innovative health monitoring, setting the stage for future enterprise opportunities. PLEASANTON, Calif.

4 months ago - PRNewsWire

Movano Inc. (MOVE) Q1 2024 Earnings Call Transcript

Movano Inc. (NASDAQ:MOVE) Q1 2024 Earnings Conference Call May 15, 2024 5:00 PM ET Company Participants John Mastrototaro - Chief Executive Officer Michael Soule - Vice President of Business Developm...

5 months ago - Seeking Alpha

Movano Health Reports Q1 2024 Financial Results and Provides Business Update

Submits exemplary Sp02 clinical trial results as part of FDA 510(k) clearance process Plans launch of Evie Med and focuses on B2B opportunities Plans arterial blood pressure study for June Conference ...

5 months ago - PRNewsWire

Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision

Unlocking business-to-business opportunities with Evie Med, Movano Health's ring pulse oximeter, remains a key priority for the Company. PLEASANTON, Calif.

5 months ago - PRNewsWire

Movano Health to Report First Quarter 2024 Financial Results on Wednesday May 15, 2024

Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif., May 6, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report first quarte...

6 months ago - PRNewsWire

Movano Inc. (MOVE) Q4 2023 Earnings Call Transcript

Movano Inc. (NASDAQ:MOVE) Q4 2023 Results Conference Call April 4, 2024 5:00 PM ET Company Participants David Barnard - Senior Vice President of Investor Relations John Mastrototaro - CEO Michael Sou...

6 months ago - Seeking Alpha

Movano Health Closes $24 Million Private Placement

Financing included a strategic seed investment by a tier-1 multi-billion dollar medical device company and participation from insiders including members of Movano Health's management team and board of...

7 months ago - PRNewsWire

Movano Health Reports 2023 Financial Results and Provides Business Update

Executes $24 million funding extending cash runway  Focuses on 2024 strategic pathway to FDA clearances driving B2B opportunities  Plans launch of Evie Med  Conference Call at 2:00 PM PT/ 5:00 PM ET T...

7 months ago - PRNewsWire

Movano Health Announces $24 Million Private Placement

Financing included a strategic seed investment by a tier-1 multi-billion dollar medical device company and participation from members of Movano Health's management team and board of directors Hosting ...

7 months ago - PRNewsWire

Movano Health Secures Strategic Investment from Tier-One Multi-Billion Dollar Medical Device Company

The seed investment and agreement underscores Movano Health's multi-analyte and  proprietary mmWave radio frequency technology PLEASANTON, Calif. , April 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq:...

7 months ago - PRNewsWire

Movano Health to Report Fourth Quarter 2023 Financial Results on Thursday, April 4, 2024

Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif. , April 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report fourth qu...

7 months ago - PRNewsWire

Movano Health Announces Evie Rings Now Shipping

PLEASANTON, Calif. , Jan. 22, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, announced that its female first wearable, the Evie Ring, will begin shipping today.

9 months ago - PRNewsWire

Movano Health and ams OSRAM Collaborate to Deliver Accurate Lifestyle Monitoring Solutions for Women

LAS VEGAS, Jan. 9, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, and ams OSRAM, a leader in technology for biometric monitoring, have collaborated to include ams O...

10 months ago - PRNewsWire

Evie, the First Women-Focused Health Ring, Takes 'Smart' to a New Level

Movano Health's 2024 CES Innovation Honoree Ships This Month LAS VEGAS , Jan. 8, 2024 /PRNewswire/ -- The Evie Ring from Movano Health (Nasdaq: MOVE), the market's first women-focused smart ring, is r...

10 months ago - PRNewsWire

Movano Health Announces HSA/FSA Eligibility for its Women First Wearable, The Evie Ring

PLEASANTON, Calif. , Dec. 18, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that its female first wearable, the Evie Ring, is now eligible for HSA/...

11 months ago - PRNewsWire

Movano Health Announces Blood Pressure Partnership Forum Following Significant Response to Groundbreaking Accuracy Achievement

PLEASANTON, Calif. , Dec. 12, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that following the successful results of its recent blood pressure clin...

11 months ago - PRNewsWire